Literature DB >> 15753238

Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing.

Rajendra A Morey1, Seniha Inan, Teresa V Mitchell, Diana O Perkins, Jeffrey A Lieberman, Aysenil Belger.   

Abstract

CONTEXT: Individuals experiencing prodromal symptoms of schizophrenia (ultra-high-risk group) demonstrate impaired performance on tasks of executive function, attention, and working memory. The neurobiological underpinnings of such executive deficits in ultra-high-risk individuals remains unclear.
OBJECTIVE: We assessed frontal and striatal functions during a visual oddball continuous performance task, in ultra-high-risk, early, and chronic schizophrenic patients with the use of functional magnetic resonance imaging.
DESIGN: Cross-sectional case-control design.
SETTING: Community; outpatient clinic. Patients Fifty-two individuals (control, n = 16; ultra-high risk, n = 10; early, n = 15; chronic, n = 11) from a referred clinical sample and age- and sex-matched control volunteers underwent scanning. MAIN OUTCOME MEASURES: Percentage of active voxels and percentage signal change calculated for the anterior cingulate gyrus (ACG), middle frontal gyrus (MFG), inferior frontal gyrus (IFG), basal ganglia, and thalamus. Performance on the visual oddball task was measured with percentage of hits and d' (a measure based on the hit rate and the false-alarm rate).
RESULTS: The ultra-high-risk group showed significantly smaller differential activation between task-relevant and task-irrelevant stimuli in the frontal regions (ACG, IFG, MFG) than the control group. Frontostriatal activation associated with target stimuli in the early and chronic groups was significantly lower than the control group, while the ultra-high-risk group showed a trend toward the early group.
CONCLUSIONS: Our findings suggest that prefrontal function begins to decline before the onset of syndromally defined illness and hence may represent a vulnerability marker in assessing the risk of developing psychotic disorders among ultra-high-risk individuals.

Entities:  

Mesh:

Year:  2005        PMID: 15753238      PMCID: PMC2732718          DOI: 10.1001/archpsyc.62.3.254

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  82 in total

1.  Progression of cerebroventricular enlargement and the subtyping of schizophrenia.

Authors:  T R Nair; J D Christensen; S J Kingsbury; N G Kumar; W M Terry; D L Garver
Journal:  Psychiatry Res       Date:  1997-07-04       Impact factor: 3.222

2.  Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia.

Authors:  L E DeLisi; M Sakuma; W Tew; M Kushner; A L Hoff; R Grimson
Journal:  Psychiatry Res       Date:  1997-07-04       Impact factor: 3.222

Review 3.  Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems.

Authors:  S Heckers
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

Review 4.  Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity.

Authors:  J A Lieberman; B B Sheitman; B J Kinon
Journal:  Neuropsychopharmacology       Date:  1997-10       Impact factor: 7.853

5.  What an archaeological dig can tell us about macro- and microcircuitry in brains of schizophrenia subjects.

Authors:  F M Benes
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

6.  Elevated dopa decarboxylase activity in living brain of patients with psychosis.

Authors:  J Reith; C Benkelfat; A Sherwin; Y Yasuhara; H Kuwabara; F Andermann; S Bachneff; P Cumming; M Diksic; S E Dyve; P Etienne; A C Evans; S Lal; M Shevell; G Savard; D F Wong; G Chouinard; A Gjedde
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

7.  Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale.

Authors:  M D Bell; P H Lysaker; J L Beam-Goulet; R M Milstein; J P Lindenmayer
Journal:  Psychiatry Res       Date:  1994-06       Impact factor: 3.222

Review 8.  The glutamatergic dysfunction hypothesis for schizophrenia.

Authors:  J T Coyle
Journal:  Harv Rev Psychiatry       Date:  1996 Jan-Feb       Impact factor: 3.732

9.  Putatively psychosis-prone subjects 10 years later.

Authors:  L J Chapman; J P Chapman; T R Kwapil; M Eckblad; M C Zinser
Journal:  J Abnorm Psychol       Date:  1994-05

10.  Information processing and social competence in chronic schizophrenia.

Authors:  D L Penn; K T Mueser; W Spaulding; D A Hope; D Reed
Journal:  Schizophr Bull       Date:  1995       Impact factor: 9.306

View more
  66 in total

Review 1.  Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis.

Authors:  Paolo Fusar-Poli
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

2.  Neurocognitive deficits in the (putative) prodrome and first episode of psychosis.

Authors:  A D Eastvold; R K Heaton; K S Cadenhead
Journal:  Schizophr Res       Date:  2007-04-30       Impact factor: 4.939

3.  White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis.

Authors:  Katherine H Karlsgodt; Tara A Niendam; Carrie E Bearden; Tyrone D Cannon
Journal:  Biol Psychiatry       Date:  2009-05-07       Impact factor: 13.382

4.  Common neural circuitry supporting volitional saccades and its disruption in schizophrenia patients and relatives.

Authors:  Jazmin Camchong; Kara A Dyckman; Benjamin P Austin; Brett A Clementz; Jennifer E McDowell
Journal:  Biol Psychiatry       Date:  2008-08-09       Impact factor: 13.382

5.  Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis.

Authors:  Nicolas A Crossley; Andrea Mechelli; Paolo Fusar-Poli; Matthew R Broome; Pall Matthiasson; Louise C Johns; Elvira Bramon; Lucia Valmaggia; Steven C R Williams; Philip K McGuire
Journal:  Hum Brain Mapp       Date:  2009-12       Impact factor: 5.038

6.  Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis.

Authors:  Paul Allen; Marc L Seal; Isabel Valli; Paolo Fusar-Poli; Cinzia Perlini; Fern Day; Stephen J Wood; Steven C Williams; Philip K McGuire
Journal:  Schizophr Bull       Date:  2009-11-23       Impact factor: 9.306

7.  White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: associations with medication, neuropsychological function, and prodromal symptoms of psychosis.

Authors:  Wendy R Kates; Amy K Olszewski; Matthew H Gnirke; Zora Kikinis; Joshua Nelson; Kevin M Antshel; Wanda Fremont; Petya D Radoeva; Frank A Middleton; Martha E Shenton; Ioana L Coman
Journal:  Schizophr Res       Date:  2014-07-25       Impact factor: 4.939

8.  fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk.

Authors:  Xiaobo Li; Craig A Branch; Babak A Ardekani; Hilary Bertisch; Chindo Hicks; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2007-08-24       Impact factor: 4.939

9.  Topographic analysis of individual activation patterns in medial frontal cortex in schizophrenia.

Authors:  Emily R Stern; Robert C Welsh; Kate D Fitzgerald; Stephan F Taylor
Journal:  Hum Brain Mapp       Date:  2009-07       Impact factor: 5.038

10.  Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia.

Authors:  Martina Ballmaier; Florian Schlagenhauf; Arthur W Toga; Jürgen Gallinat; Michael Koslowski; Michele Zoli; Cornelius Hojatkashani; Katherine L Narr; Andreas Heinz
Journal:  Schizophr Res       Date:  2008-09-24       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.